GENSPEED Biotech is member of great projects that received funding from the European Union’s HORIZON 2020 research & innovation programme. Such projects need the cooperation of a consortium of excellent research institutes and companies:
NextGen Microfluidics combines the competencies of 21 companies and research organizations along the entire value chain in development of microfluidic lab-on-a-foil systems. It will implement technologies and services that allow maximal adaptability to a vast majority of potential customer inquiries in microfluidics. GENSPEED Biotech researches on Roll-to-Roll patterning, high throughput and low cost applications.
The purpose of MedPhab pilot production line is to accelerate the commercialisation of diagnostic devices and instruments for treatment based on photonics, and to reduce the R&D cost. Based on testing the validation of the pilot production line on three application areas: hospital environment, home care devices and equipment for chemical diagnostics. GENSPEED Biotech’s goal is to further extend the molecular diagnostics capabilities.